Nurse-Led Education for Advanced Cancer

Recruiting at 1 trial location

Age: Any Age

Sex: Any

Trial Phase: Academic

Sponsor: City of Hope Medical Center

Disqualifiers: Severe mental illness, Hospice, Non-English

No Placebo Group All trial participants will receive the active study treatment (no placebo)

Compensation: Varies

Number of Visits: 11

Duration: 6 weeks

42 Participants Needed

Trial Summary

What is the purpose of this trial?

This clinical trial focuses on a nurse-led program that is designed to help patients cope with worries, fears, and uncertainty about the future. The purpose of this study is to understand if the program is helpful and practical to carry out at medical centers and community clinics. This study may help patients learn more effective ways to cope and respond to your concerns and any unhelpful thoughts.

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications.

What data supports the effectiveness of the treatment Nurse-Led Education for Advanced Cancer?

Research shows that nurse-led interventions can improve the quality of life for cancer patients and reduce healthcare service use, suggesting that nurse-led education may be beneficial for those with advanced cancer. ^{1 2 3 4 5}

Is the Nurse-Led Education for Advanced Cancer safe for humans?

The available research does not provide specific safety data for the Nurse-Led Education for Advanced Cancer, but nurse-led educational interventions are generally considered safe as they focus on providing information and support rather than medical treatments. ^{2 3 4 6 7}

How does the Nurse-Led Intervention treatment for advanced cancer differ from other treatments?

The Nurse-Led Intervention for advanced cancer is unique because it focuses on specialized education and support provided by nurses, enhancing the quality of care through advanced nursing practices. This approach emphasizes the role of nurses in managing cancer care, which is different from traditional treatments that primarily rely on medical interventions by doctors. ^{1 3 4 6 8}

Research Team

Anne Reb

Principal Investigator

City of Hope Medical Center

Eligibility Criteria

This trial is for English-speaking patients with stage III or IV lung or gynecologic cancer, who have been diagnosed at least 3 months ago and are experiencing significant fear about their cancer progressing, as shown by a score of 34 or higher on a specific questionnaire. It's not suitable for those in hospice care or with severe mental illnesses like psychosis.

Inclusion Criteria

You were diagnosed at least 3 months ago.

You have advanced gynecologic or lung cancer.

Your score on the Fear of Progression-short form questionnaire is 34 or higher.

Exclusion Criteria

Hospice enrolled

Non-English speaking

You have a serious mental illness like psychosis.

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants engage in a nurse-led intervention with 5 videoconference sessions over 6 weeks, focusing on worry management skills, values-based goal setting, and mindfulness practices.

6 weeks

5 videoconference sessions

Follow-up

Participants complete surveys and questionnaires to assess the intervention's impact on fear of progression, anxiety, depression, and mindfulness.

4 weeks

Questionnaires at baseline, 6 weeks, and 10 weeks

Treatment Details

Interventions

• Educational Intervention
• Nurse-Led Intervention

Trial Overview The study tests an educational program led by nurses aimed at helping advanced cancer patients manage their fears and uncertainties about the future. The goal is to see if this approach can improve coping strategies and whether it's feasible in medical centers and community clinics.

Participant Groups

Group I: Supportive care (videoconference, questionnaire, survey) Experimental Treatment 1 Intervention

Patients participate in 5 videoconference sessions over 30 minutes each over 6 weeks focused on worry management skills, values-based goal setting, and brief mindfulness-based practices, then complete patient workbook activities after each session over 15-20 minutes per day. Patients also complete a survey over 8 minutes at 6 weeks, an exit interview at 7 weeks, and questionnaires over 25 minutes each at baseline, 6 weeks, and 10 weeks.

Who Is Running the Clinical Trial?

City of Hope Medical Center

Lead Sponsor

Trials

614

Recruited

1,924,000+

National Cancer Institute (NCI)

Collaborator

Trials

14,080

Recruited

41,180,000+

References

1. United States pubmed.ncbi.nlm.nih.gov

Nurse-led interventions on quality of life for patients with cancer: A meta-analysis. [2022]

2. United States pubmed.ncbi.nlm.nih.gov

Effect of a Nurse-Led Psychoeducational Intervention on Healthcare Service Utilization Among Adults With Advanced Cancer. [2018]

3. England pubmed.ncbi.nlm.nih.gov

Development and Implementation of an Online Education Program on Advanced Breast Cancer for European Cancer Nurses: ABC4Nurses Project: a Brief Report. [2023]

4. England pubmed.ncbi.nlm.nih.gov

Impact of advanced nursing practice through nurse-led clinics in the care of cancer patients: A scoping review. [2021]

5. Scotland pubmed.ncbi.nlm.nih.gov

Consensus views on an advanced breast cancer education curriculum for cancer nurses: A Delphi study. [2023]

6. Scotland pubmed.ncbi.nlm.nih.gov

The development of a conceptual framework for advancing cancer nursing practice in Europe. [2003]

7. Canada pubmed.ncbi.nlm.nih.gov

Empowering patients and caregivers with knowledge: The development of a nurse-led gynecologic oncology chemotherapy education class. [2020]

8. Germany pubmed.ncbi.nlm.nih.gov

Building A High Quality Oncology Nursing Workforce Through Lifelong Learning: The De Souza Model. [2018]